Our fund invests in pioneering companies at the forefront of therapeutic innovation, from gene and cell therapies to precision medicines. Though novel drugs are our primary focus, we also support innovative revenue-stage diagnostic companies, cutting-edge medical device startups, transformative digital health technologies, revenue stage companies utilizing life science technology to pioneer transformative solutions in other fields outside healthcare, and healthcare services catalyzing the future of medicine. With backing from visionary investors, our mission is clear – fund the scientific trailblazers solving the medical mysteries of our time. By empowering these companies through strategic capital and guidance, we aim to accelerate the journey of groundbreaking treatments from bench to bedside.